View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
In 2003, the American Heart Association and the Centers for Disease Control and Prevention issued a scientific statement that suggested the use of high-sensitivity C-reactive protein, a recognized marker of inflammation, as an optional myocardial infarction risk factor measurement (Circulation. 2003;107:499-511). Compared with earlier guidelines, the statement suggested a more aggressive approach for identifying patients at risk of cardiovascular events. The increased interest in and the mounting evidence of the role of inflammation in the development of acute coronary syndrome was a major impetus for this. This article focuses on the use of high-sensitivity C-reactive protein as a nonlipid cardiovascular event risk marker and the implications for practice, education, and research.
Not a member? Join now for Free!
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top